Diomed's Collaborative PDT Partner, Axcan Pharma, Receives Approvable Letter From FDA For Treatment of Barrett's Esophagus.
Business Wire › December 04, 2002
Linked as:
Extract
Diomed's Collaborative PDT Partner, Axcan Pharma, Receives Approvable Letter From FDA For Treatment of Barrett's Esophagus.
Business Editors & Health/Medical Writers
ANDOVER, Mass.--(BUSINESS WIRE)--Dec. 4, 2002 Diomed Holdings, Inc. (AMEX: DIO) announced that Axcan P...See the full content of this document
Sponsored links
